Narrow search
Showing 1 - 6 of 6
Cover Image
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems
Woods, Beth; Fox, Aimée; Sculpher, Mark; Claxton, Karl - In: Health Economics 30 (2021) 11, pp. 2649-2666
Persistent link: https://www.econbiz.de/10012632716
Cover Image
Distributional cost effectiveness analysis of West Yorkshire low emission zone policies
Griffin, Susan; Walker, Simon; Sculpher, Mark - In: Health Economics 29 (2020) 5, pp. 567-579
Persistent link: https://www.econbiz.de/10012189201
Cover Image
Bayesian econometric modelling of observational data for cost‐effectiveness analysis : establishing the value of negative pressure wound therapy in the healing of open surgical wou...
Saramago, Pedro; Claxton, Karl; Welton, Nicky J.; … - In: Journal of the Royal Statistical Society: Series A … 183 (2020) 4, pp. 1575-1593
Persistent link: https://www.econbiz.de/10012284183
Cover Image
The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all-cause and disease specific models of mortality
Claxton, Karl; Lomas, James; Martin, Stephen - In: Health Economics 27 (2018) 6, pp. 1017-1023
Persistent link: https://www.econbiz.de/10012082304
Cover Image
Comment: Positive tails and normative dogs
Claxton, Karl - In: Health Economics 27 (2018) 10, pp. 1425-1427
Persistent link: https://www.econbiz.de/10012082356
Cover Image
Does public long‐term care expenditure improve care‐related quality of life of service users in England?
Longo, Francesco; Claxton, Karl; Lomas, James; Martin, … - In: Health Economics 30 (2021) 10, pp. 2561-2581
Persistent link: https://www.econbiz.de/10012632719